Friday, December 14, 2007

Treatment Options for the Eradication of Intestinal Protozoa. Part 3

The benzimidazole drugs (albendazole and mebendazole) have
antigiardial capacity, which relates at least in part to their power to
bind to β-tubulin and inhibit cytoskeletal duty.
Albendazole has been shown to have antigiardial action in vitro
and clinical run data military operation its therapeutic efficacy in
adults (400 mg daily for 5 days) and children.

Nitrazoxanide has broad-spectrum antiparasitic action.
Clinical trials in children and adults indicate that this is an
effective antigiardial representative with similar efficacy to the
nitroimidazole derivatives.
Nitazoxanide 100–200 mg twice daily (efficacy 85%) has been shown to be
as effective as a 5-day alimentation of metronidazole (efficacy 80%) in
children. Similar results have been reported in a proceedings in
adults. Nitazoxanide has also been shown to be effective in the
communication of combined metronidazole-resistant and
albendazole-resistant giardiasis. The efficacy of nitazoxanide has
since been confirmed by a systematic accounting. Other Voltage Agents

Mepacrine
has a similar efficacy to the nitroimidazole derivatives, but is
generally less well tolerated, and is no longer widely available
because of concerns about perniciousness.
This is a part of article Treatment Options for the Eradication of Intestinal Protozoa. Part 3 Taken from "Albendazole (Generic Albenza) Information" Information Blog

No comments: